News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
31,645 Results
Type
Article (1280)
Company Profile (10)
Press Release (30355)
Section
Business (15102)
Career Advice (45)
Deals (2058)
Drug Delivery (8)
Drug Development (3892)
Employer Resources (10)
FDA (610)
Job Trends (1080)
News (19540)
Policy (940)
Tag
2027 Biotech Beach Digital (1)
2027 Pharm Country Standard (1)
Academia (80)
Accelerated approval (7)
ADA (1)
Adcomms (3)
Allergies (15)
Alliances (754)
ALS (12)
Alzheimer's disease (128)
Antibody-drug conjugate (ADC) (60)
Approvals (683)
Artificial intelligence (27)
ASCO (28)
Autoimmune disease (14)
Automation (5)
Bankruptcy (6)
Best Places to Work (1045)
Biosimilars (7)
BioSpace Insights (6)
Biotechnology (2)
Bladder cancer (41)
Brain cancer (3)
Breast cancer (103)
Cancer (627)
Cardiovascular disease (36)
Career advice (46)
Career pathing (3)
CAR-T (28)
CDMO (6)
Celiac Disease (1)
Cell therapy (62)
Cervical cancer (5)
Clinical research (4056)
Collaboration (70)
Company closure (1)
Compensation (64)
Complete response letters (4)
COVID-19 (114)
CRISPR (3)
C-suite (29)
Data (866)
Denatured (3)
Depression (13)
Dermatology (11)
Diabetes (28)
Diagnostics (328)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (14)
Drug pricing (10)
Drug shortages (2)
Duchenne muscular dystrophy (13)
Earnings (15009)
Editorial (2)
Employer branding (2)
Employer resources (10)
Events (2529)
Executive appointments (33)
FDA (997)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (64)
Gene editing (8)
Generative AI (2)
Gene therapy (35)
GLP-1 (77)
Government (140)
Grass and pollen (1)
Guidances (180)
Healthcare (925)
Hematology (14)
HIV (14)
Huntington's disease (2)
IgA nephropathy (11)
Immunology and inflammation (21)
Immuno-oncology (4)
Indications (22)
Infectious disease (138)
Inflammatory bowel disease (16)
Inflation Reduction Act (1)
Influenza (5)
Intellectual property (12)
Interviews (6)
IPO (1580)
Job creations (113)
Job search strategy (36)
JPM (2)
Kidney cancer (4)
Labor market (7)
Layoffs (32)
Leadership (3)
Legal (115)
Liver cancer (5)
Lung cancer (112)
Lymphoma (80)
Management (4)
Manufacturing (44)
MASH (23)
Medical device (839)
Medtech (854)
Mergers & acquisitions (543)
Metabolic disorders (101)
mRNA (10)
Multiple sclerosis (12)
NASH (2)
Netherlands (1)
Neurodegenerative disease (23)
Neuropsychiatric disorders (6)
Neuroscience (224)
NextGen: Class of 2026 (256)
Non-profit (116)
Now hiring (2)
Obesity (54)
Opinion (6)
Ovarian cancer (20)
Pain (11)
Pancreatic cancer (17)
Parkinson's disease (22)
Patents (23)
Patient recruitment (24)
Peanut (3)
People (671)
Pharmaceutical (3)
Pharmacy benefit managers (4)
Phase 1 (846)
Phase 2 (1633)
Phase 3 (1889)
Pipeline (1592)
Policy (5)
Postmarket research (164)
Preclinical (227)
Press Release (1)
Prostate cancer (32)
Psychedelics (2)
Radiopharmaceuticals (23)
Rare diseases (65)
Real estate (102)
Recruiting (4)
Regulatory (972)
Reports (11)
Research institute (68)
Resumes & cover letters (4)
Rett syndrome (3)
RSV (10)
Schizophrenia (13)
Series A (10)
Series B (11)
Sickle cell disease (12)
Special edition (5)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (71)
Supply chain (6)
Tariffs (8)
Vaccines (59)
Venture capital (7)
Weight loss (37)
Women's health (9)
Date
Today (10)
Last 7 days (29)
Last 30 days (137)
Last 365 days (2414)
2026 (1709)
2025 (2371)
2024 (2592)
2023 (2661)
2022 (2983)
2021 (3188)
2020 (2525)
2019 (1980)
2018 (1629)
2017 (1227)
2016 (930)
2015 (1157)
2014 (865)
2013 (499)
2012 (626)
2011 (721)
2010 (606)
Location
Africa (31)
Alabama (3)
Alaska (1)
Arizona (16)
Asia (1793)
Australia (255)
California (1081)
Canada (285)
China (108)
Colorado (62)
Connecticut (47)
Delaware (60)
Europe (4686)
Florida (146)
Georgia (43)
Idaho (1)
Illinois (133)
India (3)
Indiana (96)
Iowa (2)
Japan (60)
Kansas (4)
Kentucky (11)
Louisiana (9)
Maine (6)
Maryland (174)
Massachusetts (755)
Michigan (32)
Minnesota (63)
Missouri (11)
Montana (2)
Nevada (12)
New Hampshire (7)
New Jersey (460)
New Mexico (1)
New York (271)
North Carolina (144)
North Dakota (1)
Northern California (580)
Ohio (32)
Oregon (3)
Pennsylvania (220)
Puerto Rico (4)
Rhode Island (2)
South America (51)
South Carolina (5)
Southern California (421)
Tennessee (14)
Texas (163)
United States (4128)
Utah (45)
Virginia (11)
Washington D.C. (5)
Washington State (94)
Wisconsin (7)
31,645 Results for "63".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Viral Capsid Development Market Size to Hit USD 840.63 Million by 2035
April 23, 2026
·
1 min read
Press Releases
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
February 22, 2026
·
8 min read
Mergers & acquisitions
Lilly Wakes Up Sleep Market With $6.3B Centessa Buy To Challenge Takeda
In the buyout, Eli Lilly picks up Centessa Pharmaceuticals’ lead asset cleminorexton, which could go toe-to-toe with Takeda’s oveporexton, currently under FDA review with a decision expected in the third quarter.
March 31, 2026
·
2 min read
·
Tristan Manalac
Press Releases
STERIS Announces Dividend of $0.63 per share - January 28, 2026
January 29, 2026
·
4 min read
Press Releases
Personalized Medicine Market Size Worth USD 1,397.63 Bn by 2035 Rising Use of Genomics Enables More Precise, Patient-specific Treatments
May 5, 2026
·
1 min read
Press Releases
The Prostate Cancer Foundation Invests $6.3 Million in Next Generation of Prostate Cancer Researchers
February 17, 2026
·
2 min read
Press Releases
Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress
June 5, 2026
·
17 min read
Press Releases
STERIS Announces Dividend of $0.63 per share
October 30, 2025
·
4 min read
Press Releases
Medical Care Technologies Inc. (OTC PINK:MDCE) Reports 63% Revenue Growth, Strong Profitability, and Significant Cash Flow Improvement in 2025
March 26, 2026
·
3 min read
Press Releases
Antiemetics Drugs Market Size Worth USD 30.63 Billion by 2034
November 12, 2025
·
1 min read
1 of 3,165
Next
